Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia

BACKGROUND & OBJECTIVES: The risk factors for clinically significant diffuse parenchymal lung abnormalities (CS-DPLA) persisting after severe coronavirus disease 2019 (COVID-19) pneumonia remain unclear. The present study was conducted to assess whether COVID-19 severity and other parameters are...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhooria, Sahajal, Arora, Siddhant, Chaudhary, Shivani, Sehgal, Inderpaul Singh, Prabhakar, Nidhi, Mohammad, Nasim, Sharma, Riya, Das, Prabir, Kumar, Yashwant, Garg, Mandeep, Puri, Goverdhan Dutt, Bhalla, Ashish, Muthu, Valliappan, Prasad, Kuruswamy Thurai, Agarwal, Ritesh, Aggarwal, Ashutosh Nath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Practice: Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443720/
https://www.ncbi.nlm.nih.gov/pubmed/37322633
http://dx.doi.org/10.4103/ijmr.ijmr_2360_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443720/
https://www.ncbi.nlm.nih.gov/pubmed/37322633
http://dx.doi.org/10.4103/ijmr.ijmr_2360_22

Ejemplares similares